Is a complete EBR/NYXH research report available?

No complete published report is available for ebr/NYXH (EBR/NYXH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EBR/NYXH (EBR/NYXH)

Euronext Brussels: EBR/NYXH · EUR

€0.85

+0.02 (+2.2%)· Recorded snapshot

Market cap	85.4M
Revenue (ttm)	21.7M
Net income (ttm)	-96M
EPS (ttm)	-€2.16
Shares out	100.1M
Volume	224,497
Beta	1.00

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.7M
Net income (ttm): -96M
EPS (ttm): -€2.16
Market cap: 85.4M

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2026-11-05
Employees	154
Employees change	-30
Employees growth	-16.29%
Enterprise value	EUR 47.6M
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2009
Industry	Medical Devices
Is primary listing	Yes
ISIN number	BE0974358906
Last earnings date	2026-08-05
Last refreshed	2026-10-29
Market cap	EUR 85.4M
Next earnings date	2026-11-05
Price	EUR 0.85
Price currency	EUR
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	ebr/NYXH
Website	https://www.nyxoah.com

Metric

Value

Amount currency

EUR

Country

Belgium

Country code

Earnings date

2026-11-05

Employees

154

Employees change

-30

Employees growth

-16.29%

Enterprise value

EUR 47.6M

Exchange

Euronext Brussels

Financial currency

EUR

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

2009

Industry

Medical Devices

Is primary listing

Yes

ISIN number

BE0974358906

Last earnings date

2026-08-05

Last refreshed

2026-10-29

Market cap

EUR 85.4M

Next earnings date

2026-11-05

Price

EUR 0.85

Price currency

EUR

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

ebr/NYXH

Website

https://www.nyxoah.com

Metric	Value
Earnings yield	-253.17%
EV/Sales	2.2x
FCF / EV yield	-155.38%
FCF yield	-86.58%
P/B ratio	1.03x
P/S ratio	3.94x
Price / tangible book value	1.03x
Sector forward P/E	22.94x
Sector P/E	29.62x

Metric

Value

Earnings yield

-253.17%

EV/Sales

2.2x

FCF / EV yield

-155.38%

FCF yield

-86.58%

P/B ratio

1.03x

P/S ratio

3.94x

Price / tangible book value

1.03x

Sector forward P/E

22.94x

Sector P/E

29.62x

Metric	Value
Gross margin	60.19%
Operating margin	-387.96%
Pretax margin	-436.37%
Profit per employee	EUR -623,403
Revenue per employee	EUR 140,669
ROA	-36.87%
ROA (5Y)	-21.78%
ROCE	-69.34%
ROE	-122.68%
ROE (5Y)	-50.46%
ROIC	-43.97%
SBC / revenue	20.63%
Tax / revenue	6.8%

Metric

Value

Gross margin

60.19%

Operating margin

-387.96%

Pretax margin

-436.37%

Profit per employee

EUR -623,403

Revenue per employee

EUR 140,669

ROA

-36.87%

ROA (5Y)

-21.78%

ROCE

-69.34%

ROE

-122.68%

ROE (5Y)

-50.46%

ROIC

-43.97%

SBC / revenue

20.63%

Tax / revenue

6.8%

Metric	Value
Gross profit growth	304.94%
Gross profit growth (Q)	439.29%
Gross profit growth 3Y	89.5%
Gross profit growth 5Y	319.81%
Revenue growth	339.15%
Revenue growth (Q)	472.76%
Revenue growth (QoQ)	20.45%
Revenue growth 3Y	92.5%
Revenue growth 5Y	119.62%

Metric

Value

Gross profit growth

304.94%

Gross profit growth (Q)

439.29%

Gross profit growth 3Y

89.5%

Gross profit growth 5Y

319.81%

Revenue growth

339.15%

Revenue growth (Q)

472.76%

Revenue growth (QoQ)

20.45%

Revenue growth 3Y

92.5%

Revenue growth 5Y

119.62%

Metric	Value
Capital expenditures	EUR -2.1M
Depreciation and amortization	EUR 1.3M
EBIT	EUR -84M
EBITDA	EUR -82.7M
EPS	EUR -2.16
FCF per share	EUR -0.74
Financing cash flow	EUR 128.3M
Free cash flow	EUR -73.9M
Free cash flow minus SBC	EUR -78.4M
Gross profit	EUR 13M
Income taxes	EUR 1.5M
Investing cash flow	EUR -16.2M
Net borrowing	EUR 34.9M
Net cash flow	EUR 41.4M
Net income	EUR -96M
Operating cash flow minus SBC	EUR -76.3M
Operating income	EUR -84M
Revenue	EUR 21.7M
Stock-based compensation	EUR 4.5M

Metric

Value

Capital expenditures

EUR -2.1M

Depreciation and amortization

EUR 1.3M

EBIT

EUR -84M

EBITDA

EUR -82.7M

EPS

EUR -2.16

FCF per share

EUR -0.74

Financing cash flow

EUR 128.3M

Free cash flow

EUR -73.9M

Free cash flow minus SBC

EUR -78.4M

Gross profit

EUR 13M

Income taxes

EUR 1.5M

Investing cash flow

EUR -16.2M

Net borrowing

EUR 34.9M

Net cash flow

EUR 41.4M

Net income

EUR -96M

Operating cash flow minus SBC

EUR -76.3M

Operating income

EUR -84M

Revenue

EUR 21.7M

Stock-based compensation

EUR 4.5M

Metric	Value
Altman Z-Score	-2.8
Book value per share	EUR 0.83
Debt / equity	0.72
Interest coverage	-24.59
Long-term assets	EUR 55.8M
Long-term liabilities	EUR 38.1M
Net cash (debt)	EUR 37.8M
Net cash / market cap	44.28%
Net cash growth	83.62%
Net debt / equity	-0.45
Piotroski F-Score	2
Property, plant and equipment	EUR 5.9M
Shareholders' equity	EUR 83.1M
Tangible book value	EUR 82.8M
Tangible book value per share	EUR 0.83
Total assets	EUR 168.5M
Total cash	EUR 97.8M
Total debt	EUR 60M
Total liabilities	EUR 85.4M
WACC	7.59%

Metric

Value

Altman Z-Score

-2.8

Book value per share

EUR 0.83

Debt / equity

0.72

Interest coverage

-24.59

Long-term assets

EUR 55.8M

Long-term liabilities

EUR 38.1M

Net cash (debt)

EUR 37.8M

Net cash / market cap

44.28%

Net cash growth

83.62%

Net debt / equity

-0.45

Piotroski F-Score

Property, plant and equipment

EUR 5.9M

Shareholders' equity

EUR 83.1M

Tangible book value

EUR 82.8M

Tangible book value per share

EUR 0.83

Total assets

EUR 168.5M

Total cash

EUR 97.8M

Total debt

EUR 60M

Total liabilities

EUR 85.4M

WACC

7.59%

Metric	Value
Asset turnover	0.15
Current assets	EUR 112.7M
Current liabilities	EUR 47.3M
Current ratio	2.38
Inventory turnover	1.91
Net working capital	EUR -8.7M
Quick ratio	2.28
Working capital	EUR 65.4M
Working capital turnover	0.44

Metric

Value

Asset turnover

0.15

Current assets

EUR 112.7M

Current liabilities

EUR 47.3M

Current ratio

2.38

Inventory turnover

1.91

Net working capital

EUR -8.7M

Quick ratio

2.28

Working capital

EUR 65.4M

Working capital turnover

0.44

Metric	Value
Buyback yield / dilution	-21.45%
Shareholder yield	-21.45%

Metric

Value

Buyback yield / dilution

-21.45%

Shareholder yield

-21.45%

Metric	Value
150-day SMA	EUR 1.71
1D price change	2.16%
1M price change	-33.36%
1M total return	-33.36%
1W price change	0.12%
1W total return	0.12%
1Y price change	-81.46%
1Y return CAGR	-81.48%
1Y total return	-81.46%
20-day SMA	EUR 1.04
200-day SMA	EUR 2.17
3M price change	-31.87%
3M total return	-31.87%
3Y price change	-85.44%
3Y return CAGR	-47.39%
3Y total return	-85.44%
50-day SMA	EUR 1.23
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 5.14
52-week high date	2025-11-13
52-week low	EUR 0.70
52-week low date	2026-10-22
5Y price change	-95.84%
5Y return CAGR	-47.06%
5Y total return	-95.84%
6M price change	-67.19%
6M total return	-67.19%
All-time high	EUR 30.00
All-time high date	2021-07-13
All-time low	EUR 0.70
All-time low date	2026-10-22
Average true range (ATR)	EUR 0.09
Average volume	272.3K
Beta (1Y)	1.55
Beta (2Y)	0.99
Beta (5Y)	1
Change from 52-week high	-83.4%
Change from 52-week low	22.38%
Change from all-time high	-97.16%
Change from all-time low	22.38%
Change from open	-0.47%
Day's gap	2.63%
Dollar volume	EUR 191,496
High price	EUR 0.90
Low price	EUR 0.84
Monthly RSI	30.39
Open price	EUR 0.86
Position in 52-week range	20.63%
Previous close	EUR 0.84
Price vs 150-day SMA	-50.23%
Price vs 20-day SMA	-17.66%
Price vs 200-day SMA	-60.71%
Price vs 50-day SMA	-30.59%
Relative volume	0.82
RSI	34.98
Sharpe ratio	-1.75
Sharpe ratio (3Y)	-0.33
Sharpe ratio (5Y)	-0.56
Sortino ratio	-2.06
Sortino ratio (3Y)	-0.39
Sortino ratio (5Y)	-0.71
Volume	224.5K
Weekly RSI	26.58
YTD price change	-79.12%
YTD total return	-79.12%

Metric

Value

150-day SMA

EUR 1.71

1D price change

2.16%

1M price change

-33.36%

1M total return

-33.36%

1W price change

0.12%

1W total return

0.12%

1Y price change

-81.46%

1Y return CAGR

-81.48%

1Y total return

-81.46%

20-day SMA

EUR 1.04

200-day SMA

EUR 2.17

3M price change

-31.87%

3M total return

-31.87%

3Y price change

-85.44%

3Y return CAGR

-47.39%

3Y total return

-85.44%

50-day SMA

EUR 1.23

50-day SMA vs 200-day SMA

50under200

52-week high

EUR 5.14

52-week high date

2025-11-13

52-week low

EUR 0.70

52-week low date

2026-10-22

5Y price change

-95.84%

5Y return CAGR

-47.06%

5Y total return

-95.84%

6M price change

-67.19%

6M total return

-67.19%

All-time high

EUR 30.00

All-time high date

2021-07-13

All-time low

EUR 0.70

All-time low date

2026-10-22

Average true range (ATR)

EUR 0.09

Average volume

272.3K

Beta (1Y)

1.55

Beta (2Y)

0.99

Beta (5Y)

Change from 52-week high

-83.4%

Change from 52-week low

22.38%

Change from all-time high

-97.16%

Change from all-time low

22.38%

Change from open

-0.47%

Day's gap

2.63%

Dollar volume

EUR 191,496

High price

EUR 0.90

Low price

EUR 0.84

Monthly RSI

30.39

Open price

EUR 0.86

Position in 52-week range

20.63%

Previous close

EUR 0.84

Price vs 150-day SMA

-50.23%

Price vs 20-day SMA

-17.66%

Price vs 200-day SMA

-60.71%

Price vs 50-day SMA

-30.59%

Relative volume

0.82

RSI

34.98

Sharpe ratio

-1.75

Sharpe ratio (3Y)

-0.33

Sharpe ratio (5Y)

-0.56

Sortino ratio

-2.06

Sortino ratio (3Y)

-0.39

Sortino ratio (5Y)

-0.71

Volume

224.5K

Weekly RSI

26.58

YTD price change

-79.12%

YTD total return

-79.12%

Metric	Value
Float	50.9M
Shares change (QoQ)	31.87%
Shares change (YoY)	21.45%
Shares held by insiders	26.26%
Shares held by institutions	12.62%
Shares outstanding	100.1M

Metric

Value

Float

50.9M

Shares change (QoQ)

31.87%

Shares change (YoY)

21.45%

Shares held by insiders

26.26%

Shares held by institutions

12.62%

Shares outstanding

100.1M

EBR/NYXH (EBR/NYXH)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/NYXH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/NYXH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/NYXH

Frequently asked questions